ribociclib
novartis
['kisqali', 'breast', 'novartis']
kisqali, made by novartis, cuts risk of recurrence of early hr+/her2- (most common type) breast cancer by 25% - from #asco23 
Medical correspondent @CNN (prev: @CNBC)
Co-host @statnews’ the Readout Loud podcast